Related Experiment Video
Updated: Mar 1, 2026
23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
84.6K
Clinical Stroke prevention in atrial fibrillation
C Voukalis1, E Shantsila, G Y Lip
1GYH Lip, University of Birmingham, Institute of Cardiovascular Sciences, City Hospital, Birmingham B18 7QH, UK.
Summary
Oral anticoagulation therapy, including novel non-vitamin K oral anticoagulants, significantly reduces stroke risk in atrial fibrillation. Balancing bleeding and stroke risks with individualized patient care is crucial for effective management.
Area of Science:
- Cardiology
- Neurology
- Pharmacology
Background:
- Oral anticoagulation therapy is vital for managing atrial fibrillation, reducing ischemic stroke risk and improving patient outcomes.
- Non-vitamin K oral anticoagulants (NOACs) have emerged as key alternatives to vitamin K antagonists (VKAs), transforming stroke prevention strategies.
- Bleeding is a primary complication of antithrombotic therapy, necessitating careful risk-benefit assessment.
Purpose of the Study:
- To review current knowledge on oral anticoagulation in atrial fibrillation patients.
- To guide physicians in managing anticoagulants based on clinical trial and systematic review data.
- To emphasize the importance of balancing ischemic stroke risk against intracranial hemorrhage risk.
Main Methods:
- Systematic review of clinical trials and existing literature.
- Analysis of data on efficacy and safety of oral anticoagulants.
- Evaluation of risk stratification and management strategies.
Main Results:
- Oral anticoagulants significantly reduce ischemic stroke risk in atrial fibrillation.
- NOACs offer an alternative to VKAs with varying profiles.
- Individualized patient management is essential due to heterogeneous risks and preferences.
Conclusions:
- Effective anticoagulation management requires balancing stroke prevention with bleeding risk.
- Physicians must adopt an individualized approach for atrial fibrillation patients on oral anticoagulants.
- Current data support the use of oral anticoagulants for stroke prevention in atrial fibrillation.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
425
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
425
01:23Atherosclerosis IV: Nursing Management
532
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
532
01:26Coronary Artery Disease IV: Preventive Measures
773
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
773
01:26Atherosclerosis III: Management
520
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
520
01:27Regulation of Stroke Volume
5.4K
The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
5.4K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K